NCT03516110View on ClinicalTrials.gov

Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy

CompletedOBSERVATIONAL

Enrollment

831

Participants

Timeline

Start Date

March 9, 2018

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions

Prostate Cancer

Interventions

OTHER

Data collection

Subjects will be treated in accordance with usual medical practice during their participation in this study. No additional assessments or tests will be required.

Trial Locations (1)

Unknown

Ipsen Central Contact, Paris